ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Entasis Therapeutics Holdings Inc

Entasis Therapeutics Holdings Inc (ETTX)

2.19
0.00
(0.00%)
Closed October 05 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.19
Bid
2.21
Ask
2.19
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
2.19
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ETTX Latest News

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022

WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc., a late-stage clinical biopharmaceutical company focused on the discovery and development of novel...

Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entasis Therapeutics Holdings Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entasis Therapeutics Holdings Inc. PR Newswire NEW YORK, May 24, 2022 NEW YORK, May 24, 2022 /PRNewswire/ -- Rowley Law PLLC is...

Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK Trial

SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patients Statistically significant difference in clinical cure at...

Entasis Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

– ATTACK Phase 3 topline data readout remains on track for second half of 2021 –            – Strengthened balance sheet with $20M financing – WALTHAM, Mass., May 05, 2021 (GLOBE NEWSWIRE...

Entasis Therapeutics Completes Initial Closing of $20M Private Placement with Innoviva

WALTHAM, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...

Entasis Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update

– Phase 3 ATTACK registration trial more than three-quarters complete –– ATTACK topline data readout expected second half of 2021 –– Zoliflodacin Phase 3 trial adds clinical trial sites, continues...

Entasis Therapeutics Announces Sulbactam-Durlobactam Expanded Access Program for Patients in the U.S.

WALTHAM, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...

Entasis Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference

WALTHAM, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...

Entasis Therapeutics to Participate in A.G.P.’s Virtual Healthcare Symposium

WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CHSNChanson International Holding
$ 11.22
(269.08%)
14.76M
PEVPhoenix Motor Inc
$ 1.0607
(205.24%)
228.42M
ENTOEntero Therapeutics Inc
$ 0.60
(72.20%)
10.42M
BENFBeneficient
$ 1.8914
(58.94%)
108.31M
FORDForward Industries Inc
$ 5.3254
(52.15%)
18.45M
ADDColor Star Technology Company Ltd
$ 0.2701
(-39.98%)
14.35M
DUOFangDD Network Group Ltd
$ 2.53
(-32.89%)
27.74M
ICCTiCoreConnect Inc
$ 0.4102
(-31.50%)
1.65M
ZENAZenaTech Inc
$ 3.91
(-29.55%)
212.12k
SPAISafe Pro Group Inc
$ 1.93
(-25.77%)
238.67k
NVDANVIDIA Corporation
$ 124.92
(1.68%)
244.46M
PEVPhoenix Motor Inc
$ 1.0607
(205.24%)
228.42M
SQQQProShares UltraPro Short QQQ
$ 7.43
(-3.63%)
184.47M
NCNCnoco noco Inc
$ 0.144
(8.60%)
147.38M
BENFBeneficient
$ 1.8914
(58.94%)
108.31M

ETTX Discussion

View Posts
Pedro2004 Pedro2004 3 years ago
Yes...keep an eye on this for a later date. Once they're finished with the selling, this should pop.
👍️0
swampboots swampboots 3 years ago
Ok that explains the $1 dollar fall from highs, last night.
👍️0
Pedro2004 Pedro2004 3 years ago
We have entered into an Controlled Equity Offering SM Sales Agreement (the “sales agreement”) with Cantor Fitzgerald & Co. (“Cantor”), dated as of August 27, 2021, relating to the offer and sale of shares of our common stock. In accordance with the terms of the sales agreement, under this prospectus supplement and the accompanying prospectus, we may offer and sell shares of our common stock having an aggregate offering price of up to $17,500,000 from time to time through Cantor acting as sales agent.
👍️0
swampboots swampboots 3 years ago
ETTX $+ data confirms, what is addressable market?
👍️0
frugalNorwegian frugalNorwegian 3 years ago
New reddit group talking only about ETTX.

https://reddit.com/r/ETTX_Stock
👍️0
BooDog BooDog 3 years ago
Very cool. I took my eyes off this one at the wrong time!

Nice!
👍️0
Snug Harbour Snug Harbour 3 years ago
Ya Baby!
👍️0
BooDog BooDog 4 years ago
2.73 high, who knew
👍️0
BooDog BooDog 4 years ago
Interesting looking charts. Something cooking here?
👍️0
BooDog BooDog 4 years ago
In 1.85 this morning pre market. See how this goes, BOD looks pretty solid.
👍️0
Sluicebox Sluicebox 4 years ago
Super odd, they're selling the stocks and warrants they bought in the September offer @2,67, so selling with a loss ?
The week before data ?
What do they know today that they didn't know back in September?
👍️0
dirtydozen911 dirtydozen911 4 years ago
doing a little digging...........the prospectus filed a few days ago is NOT the company selling shares....it is 2 of its largest holders JUMPING SHIP !!.......innoviva and armistice capital

they combined , are selling over 18 million shares, or about half the O S .....if the 35,475,441 is accurate.....i see why they tried to pump this early this morn.......i suspect massive selling today

DANGER...DANGER............GLA
👍️0
dirtydozen911 dirtydozen911 4 years ago
offering announced 3 days ago.....prob get hit with it at 4 p m ..gl
👍️0
Covid19freak Covid19freak 4 years ago
Great buying opportunity here close at ATL ,,,dirt cheap stock at $72 million valuation which has 2 phase 3 drugs with first readout expected next quarter . A potential 10 bagger and more here ..GL

Presentation October
https://investors.entasistx.com/static-files/0bf75506-2d54-4b14-896a-6a3d5ed53472

Major Shareholders

Innoviva Inc ...18.7M
Armistice ...3.5M
AstraZeneca PLC ...2.2M
Clarus Ventures, LLC ...1.3M
Pivotal ...1.2M
Sofinnova ...1.2M
Novo Holdings A/S ...1.2M
TPG Capital, L.P....1.0M
Eventide Asset ...879.5K
Frazier ...350.0K


👍️0
swingingRichard swingingRichard 4 years ago
This is awesome. Trusted the model and averaged down just twice.
👍️0
swingingRichard swingingRichard 4 years ago
$ETTX Sold too early. Made only %28. The model works!!!!

HOTD (so far was $4.25). Still, I'll take 28% any day of the week. So far this year, no losing plays using the model. Now, to be fair, I did have some losing trades, things I should have just left alone after making 150%.

* * * Chart Analysis * * *
👍️0
BioSpecialist BioSpecialist 4 years ago
Dirt cheap biotech gem

ETTX =MC $80 M / Cash $63 M / 2 MEGA Drugs with Phase 3 readouts in short term /Undiscovered low float stock
👍️0
BioSpecialist BioSpecialist 4 years ago
(ETTX-DD) Low Valuation of $86 Million / STRONG Cash of $63 Million/ 2 attractive Drugs in late Phase 3 with LARGE market potential with first readout within 6-7 months / Insider & Institutional investors holding most of the shares /Low float stock = $15-20 stock here on this undiscovered biotech gem .GL


Presentation June
https://investors.entasistx.com/static-files/0bf75506-2d54-4b14-896a-6a3d5ed53472

Major Shareholders

Innoviva Inc...14M
Novo Holdings A/S...2.2M
AstraZeneca PLC...2.2M
Clarus Ventures, LLC...1.6M
Pivotal ...1.2M
Sofinnova ...1.2M
Frazier ...1.0M
TPG Capital, L.P...1.0M
Eventide Asset ...879.5K
Granahan ...154.7K



👍️0
Wild Wild West Wild Wild West 4 years ago
Big move coming here IMO

Giddy up ETTX
👍️0

Your Recent History

Delayed Upgrade Clock